Hookipa Biotech AG is a privately held, clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology.
Location: Austria
Total raised: $59.6M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 11.12.2017 | Series C | $59.6M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 12.12.2017 | Term Sheet — Tuesday, December 12 | 2018 CRYSTAL BALL Good morning, Term Sheet readers. Paid Content You can't secure what you can't s... | fortune.co... |
| 11.12.2017 | Hookipa Biotech Raises $59.6M in Series C Financing Round | Hookipa Biotech AG, a Vienna, Austria-based clinical stage biotech company, raised $59.6m (€50.0m) i... | finsmes.co... |
| 04.11.2013 | Hookipa Biotech Raises €20M in Series B Equity Financing | Hookipa Biotech AG, a Vienna, Austria-based developer of a new class of vaccines, raised €20m ($27.5... | finsmes.co... |